Here are four insights:
1. The coflex device is a non-fusion, motion preserving stabilization implant, and FDA-approved for lumbar spinal stenosis treatment.
2. Paradigm Spine’s device can be used in conjunction with a decompression or in substitute of a spinal fusion.
3. The stabilization implant has more than 20 years of clinical history and is used to treat patients in more than 40 countries. Marc Viscogliois, chairman and CEO of Paradigm Spine, said, “With over 85 peer-review published articles, including landmark five year follow-up studies, medical society guidelines, and now
with additional commercial insurance coverage, it is wonderful to be able to expand patient access to coflex technology.”
4. Health Alliance Plan of Michigan provides coverage to more than 500,000 people, and it is estimated that lumbar spinal stenosis affects 1.6 million patients annually.
More articles on MIS:
Dr. Jae Lim performs 100+ spine surgeries with Mazor Renaissance — 4 points
Endoscopic spine surgery arrives in China, Dr. Anthony Yeung unveils Yeung Spine Society: 6 insights
Southern Spine highlights review published on StabiLink MIS Interlaminar Spinal Fixation System: 4 takeaways
